1. Study of United Kingdom product licence applications containing new active substances, 1987-9.;Rawlins;Br Med J,1991
2. Committee on Safety of Drugs Report for 1969 HMSO 1971
3. Mann RD The yellow card data: the nature and scale of the adverse drug reactions problems. In Adverse drug reactions 62 63
4. The incidence of the most commonly reported events with 40newly marketed drugs-a study by Prescription-Event Monitoring.;Freemantle;Pharmacoepidemiology and Drug Safety,1997
5. British Medical Association Reporting Adverse Drug Reactions. A BMA policy document 1996